Catalent Launches FlexDirect


Applied Clinical Trials

Catalent has announced the launch of FlexDirect, a new direct-to-patient service for clinical trials. The FlexDirect service provides sponsors with the choice of site-to-patient distribution, or Catalent’s new pharmacy-to-patient service.

For more information, click here. 

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.